Skin is widely used as a drug delivery route due to its easy access and the possibility of using relatively painless methods for the administration of bioactive molecules.However,the barrier properties of the skin,alo...Skin is widely used as a drug delivery route due to its easy access and the possibility of using relatively painless methods for the administration of bioactive molecules.However,the barrier properties of the skin,along with its multilayer structure,impose severe restrictions on drug transport and bioavailability.Thus,bioengineered models aimed at emulating the skin have been developed not only for optimizing the transdermal transport of different drugs and testing the safety and toxicity of substances but also for understanding the biological processes behind skin wounds.Even though in vivo research is often preferred to study biological processes involving the skin,in vitro and ex vivo strategies have been gaining increasing relevance in recent years.Indeed,there is a noticeably increasing adoption of in vitro and ex vivo methods by internationally accepted guidelines.Furthermore,microfluidic organ-on-a-chip devices are nowadays emerging as valuable tools for functional and behavioural skin emulation.Challenges in miniaturization,automation and reliability still need to be addressed in order to create skin models that can predict skin behaviour in a robust,high-throughput manner,while being compliant with regulatory issues,standards and guidelines.In this review,skin models for transdermal transport,wound repair and cutaneous toxicity will be discussed with a focus on high-throughput strategies.Novel microfluidic strategies driven by advancements in microfabrication technologies will also be revised as a way to improve the efficiency of existing models,both in terms of complexity and throughput.展开更多
基金supported by Portuguese funds from the Foundation for Science and Technology(FCT)(projects i3S,ref.UID/BIM/04293/2020,SKINCHIP,ref.PTDC/BBBBIO/1889/2014,iMed.ULisboa,refs.UID/DTP/04138/2020 and UIDB/DTP/04138/2020)UK funds from the Engineering and Physical Sciences Research Council(EPSRC)and Medical Research Council(MRC)(projects Centre for Doctoral Training in Regenerative Medicine,ref.EP/L014904/1,and Henry Royce Institute for Advanced Materials,refs.EP/R00661X/1,EP/P025021/1 and EP/P025498/1).
文摘Skin is widely used as a drug delivery route due to its easy access and the possibility of using relatively painless methods for the administration of bioactive molecules.However,the barrier properties of the skin,along with its multilayer structure,impose severe restrictions on drug transport and bioavailability.Thus,bioengineered models aimed at emulating the skin have been developed not only for optimizing the transdermal transport of different drugs and testing the safety and toxicity of substances but also for understanding the biological processes behind skin wounds.Even though in vivo research is often preferred to study biological processes involving the skin,in vitro and ex vivo strategies have been gaining increasing relevance in recent years.Indeed,there is a noticeably increasing adoption of in vitro and ex vivo methods by internationally accepted guidelines.Furthermore,microfluidic organ-on-a-chip devices are nowadays emerging as valuable tools for functional and behavioural skin emulation.Challenges in miniaturization,automation and reliability still need to be addressed in order to create skin models that can predict skin behaviour in a robust,high-throughput manner,while being compliant with regulatory issues,standards and guidelines.In this review,skin models for transdermal transport,wound repair and cutaneous toxicity will be discussed with a focus on high-throughput strategies.Novel microfluidic strategies driven by advancements in microfabrication technologies will also be revised as a way to improve the efficiency of existing models,both in terms of complexity and throughput.
